組換えDNA技術の世界市場（～2026年）

• 英文タイトル：Global Recombinant DNA Technology Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04469 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は組換えDNA技術のグローバル市場について調査・分析したレポートです。種類別（治療薬、ワクチン、遺伝子組換え作物、特殊化学品）市場規模、用途別（バイオテクノロジーおよび製薬会社、学術および政府研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別組換えDNA技術の競争状況、市場シェア ・世界の組換えDNA技術市場：種類別市場規模 2015年-2020年（治療薬、ワクチン、遺伝子組換え作物、特殊化学品） ・世界の組換えDNA技術市場：種類別市場規模予測 2021年-2026年（治療薬、ワクチン、遺伝子組換え作物、特殊化学品） ・世界の組換えDNA技術市場：用途別市場規模 2015年-2020年（バイオテクノロジーおよび製薬会社、学術および政府研究所、その他） ・世界の組換えDNA技術市場：用途別市場規模予測 2021年-2026年（バイオテクノロジーおよび製薬会社、学術および政府研究所、その他） ・北米の組換えDNA技術市場分析：米国、カナダ ・ヨーロッパの組換えDNA技術市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの組換えDNA技術市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の組換えDNA技術市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの組換えDNA技術市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Monsanto Company、Roche、Biogen、Amgen、Novartis、Eli Lilly and Company、GenScript、Pfizer Inc.、Novo Nordisk、Sanofi、Merck KGaA、Profacgen、Biocon、GlaxoSmithKline、Cibus、Horizon Discovery Group、New England Biolabs ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Recombinant DNA Technology Market
The global Recombinant DNA Technology market size is projected to reach US$ 511.5 million by 2026, from US$ 490.8 million in 2020, at a CAGR of 3.9%% during 2021-2026.

Global Recombinant DNA Technology Scope and Market Size
Recombinant DNA Technology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant DNA Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs

Market segment by Type, the product can be split into
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals
Market segment by Application, split into
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant DNA Technology Revenue
1.4 Market by Type
1.4.1 Global Recombinant DNA Technology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Therapeutic Agent
1.4.3 Vaccine
1.4.4 Biotech Crops
1.4.5 Specialty Chemicals
1.5 Market by Application
1.5.1 Global Recombinant DNA Technology Market Share by Application: 2020 VS 2026
1.5.2 Biotechnology and Pharmaceutical Companies
1.5.3 Academic & Government Research Institutes
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Recombinant DNA Technology Market Perspective (2015-2026)
2.2 Global Recombinant DNA Technology Growth Trends by Regions
2.2.1 Recombinant DNA Technology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Recombinant DNA Technology Historic Market Share by Regions (2015-2020)
2.2.3 Recombinant DNA Technology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Recombinant DNA Technology Market Growth Strategy
2.3.6 Primary Interviews with Key Recombinant DNA Technology Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Recombinant DNA Technology Players by Market Size
3.1.1 Global Top Recombinant DNA Technology Players by Revenue (2015-2020)
3.1.2 Global Recombinant DNA Technology Revenue Market Share by Players (2015-2020)
3.1.3 Global Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant DNA Technology Market Concentration Ratio
3.2.1 Global Recombinant DNA Technology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Recombinant DNA Technology Revenue in 2019
3.3 Recombinant DNA Technology Key Players Head office and Area Served
3.4 Key Players Recombinant DNA Technology Product Solution and Service
3.5 Date of Enter into Recombinant DNA Technology Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Recombinant DNA Technology Historic Market Size by Type (2015-2020)
4.2 Global Recombinant DNA Technology Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Recombinant DNA Technology Market Size by Application (2015-2020)
5.2 Global Recombinant DNA Technology Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Recombinant DNA Technology Market Size (2015-2020)
6.2 Recombinant DNA Technology Key Players in North America (2019-2020)
6.3 North America Recombinant DNA Technology Market Size by Type (2015-2020)
6.4 North America Recombinant DNA Technology Market Size by Application (2015-2020)

7 Europe
7.1 Europe Recombinant DNA Technology Market Size (2015-2020)
7.2 Recombinant DNA Technology Key Players in Europe (2019-2020)
7.3 Europe Recombinant DNA Technology Market Size by Type (2015-2020)
7.4 Europe Recombinant DNA Technology Market Size by Application (2015-2020)

8 China
8.1 China Recombinant DNA Technology Market Size (2015-2020)
8.2 Recombinant DNA Technology Key Players in China (2019-2020)
8.3 China Recombinant DNA Technology Market Size by Type (2015-2020)
8.4 China Recombinant DNA Technology Market Size by Application (2015-2020)

9 Japan
9.1 Japan Recombinant DNA Technology Market Size (2015-2020)
9.2 Recombinant DNA Technology Key Players in Japan (2019-2020)
9.3 Japan Recombinant DNA Technology Market Size by Type (2015-2020)
9.4 Japan Recombinant DNA Technology Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Recombinant DNA Technology Market Size (2015-2020)
10.2 Recombinant DNA Technology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Recombinant DNA Technology Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant DNA Technology Market Size by Application (2015-2020)

11 India
11.1 India Recombinant DNA Technology Market Size (2015-2020)
11.2 Recombinant DNA Technology Key Players in India (2019-2020)
11.3 India Recombinant DNA Technology Market Size by Type (2015-2020)
11.4 India Recombinant DNA Technology Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Recombinant DNA Technology Market Size (2015-2020)
12.2 Recombinant DNA Technology Key Players in Central & South America (2019-2020)
12.3 Central & South America Recombinant DNA Technology Market Size by Type (2015-2020)
12.4 Central & South America Recombinant DNA Technology Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Monsanto Company
13.1.1 Monsanto Company Company Details
13.1.2 Monsanto Company Business Overview
13.1.3 Monsanto Company Recombinant DNA Technology Introduction
13.1.4 Monsanto Company Revenue in Recombinant DNA Technology Business (2015-2020))
13.1.5 Monsanto Company Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Recombinant DNA Technology Introduction
13.2.4 Roche Revenue in Recombinant DNA Technology Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Biogen
13.3.1 Biogen Company Details
13.3.2 Biogen Business Overview
13.3.3 Biogen Recombinant DNA Technology Introduction
13.3.4 Biogen Revenue in Recombinant DNA Technology Business (2015-2020)
13.3.5 Biogen Recent Development
13.4 Amgen
13.4.1 Amgen Company Details
13.4.2 Amgen Business Overview
13.4.3 Amgen Recombinant DNA Technology Introduction
13.4.4 Amgen Revenue in Recombinant DNA Technology Business (2015-2020)
13.4.5 Amgen Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Recombinant DNA Technology Introduction
13.5.4 Novartis Revenue in Recombinant DNA Technology Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Eli Lilly and Company
13.6.1 Eli Lilly and Company Company Details
13.6.2 Eli Lilly and Company Business Overview
13.6.3 Eli Lilly and Company Recombinant DNA Technology Introduction
13.6.4 Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2015-2020)
13.6.5 Eli Lilly and Company Recent Development
13.7 GenScript
13.7.1 GenScript Company Details
13.7.2 GenScript Business Overview
13.7.3 GenScript Recombinant DNA Technology Introduction
13.7.4 GenScript Revenue in Recombinant DNA Technology Business (2015-2020)
13.7.5 GenScript Recent Development
13.8 Pfizer Inc.
13.8.1 Pfizer Inc. Company Details
13.8.2 Pfizer Inc. Business Overview
13.8.3 Pfizer Inc. Recombinant DNA Technology Introduction
13.8.4 Pfizer Inc. Revenue in Recombinant DNA Technology Business (2015-2020)
13.8.5 Pfizer Inc. Recent Development
13.9 Novo Nordisk
13.9.1 Novo Nordisk Company Details
13.9.2 Novo Nordisk Business Overview
13.9.3 Novo Nordisk Recombinant DNA Technology Introduction
13.9.4 Novo Nordisk Revenue in Recombinant DNA Technology Business (2015-2020)
13.9.5 Novo Nordisk Recent Development
13.10 Sanofi
13.10.1 Sanofi Company Details
13.10.2 Sanofi Business Overview
13.10.3 Sanofi Recombinant DNA Technology Introduction
13.10.4 Sanofi Revenue in Recombinant DNA Technology Business (2015-2020)
13.10.5 Sanofi Recent Development
13.11 Merck KGaA
10.11.1 Merck KGaA Company Details
10.11.2 Merck KGaA Business Overview
10.11.3 Merck KGaA Recombinant DNA Technology Introduction
10.11.4 Merck KGaA Revenue in Recombinant DNA Technology Business (2015-2020)
10.11.5 Merck KGaA Recent Development
13.12 Profacgen
10.12.1 Profacgen Company Details
10.12.2 Profacgen Business Overview
10.12.3 Profacgen Recombinant DNA Technology Introduction
10.12.4 Profacgen Revenue in Recombinant DNA Technology Business (2015-2020)
10.12.5 Profacgen Recent Development
13.13 Biocon
10.13.1 Biocon Company Details
10.13.2 Biocon Business Overview
10.13.3 Biocon Recombinant DNA Technology Introduction
10.13.4 Biocon Revenue in Recombinant DNA Technology Business (2015-2020)
10.13.5 Biocon Recent Development
13.14 GlaxoSmithKline
10.14.1 GlaxoSmithKline Company Details
10.14.2 GlaxoSmithKline Business Overview
10.14.3 GlaxoSmithKline Recombinant DNA Technology Introduction
10.14.4 GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2015-2020)
10.14.5 GlaxoSmithKline Recent Development
13.15 Cibus
10.15.1 Cibus Company Details
10.15.2 Cibus Business Overview
10.15.3 Cibus Recombinant DNA Technology Introduction
10.15.4 Cibus Revenue in Recombinant DNA Technology Business (2015-2020)
10.15.5 Cibus Recent Development
13.16 Horizon Discovery Group
10.16.1 Horizon Discovery Group Company Details
10.16.2 Horizon Discovery Group Business Overview
10.16.3 Horizon Discovery Group Recombinant DNA Technology Introduction
10.16.4 Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2015-2020)
10.16.5 Horizon Discovery Group Recent Development
13.17 New England Biolabs
10.17.1 New England Biolabs Company Details
10.17.2 New England Biolabs Business Overview
10.17.3 New England Biolabs Recombinant DNA Technology Introduction
10.17.4 New England Biolabs Revenue in Recombinant DNA Technology Business (2015-2020)
10.17.5 New England Biolabs Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Recombinant DNA Technology Key Market Segments
Table 2. Key Players Covered: Ranking by Recombinant DNA Technology Revenue
Table 3. Ranking of Global Top Recombinant DNA Technology Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Recombinant DNA Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Therapeutic Agent
Table 6. Key Players of Vaccine
Table 7. Key Players of Biotech Crops
Table 8. Key Players of Specialty Chemicals
Table 9. Global Recombinant DNA Technology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Recombinant DNA Technology Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Recombinant DNA Technology Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Recombinant DNA Technology Market Share by Regions (2015-2020)
Table 13. Global Recombinant DNA Technology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Recombinant DNA Technology Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Recombinant DNA Technology Market Growth Strategy
Table 19. Main Points Interviewed from Key Recombinant DNA Technology Players
Table 20. Global Recombinant DNA Technology Revenue by Players (2015-2020) (Million US$)
Table 21. Global Recombinant DNA Technology Market Share by Players (2015-2020)
Table 22. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA Technology as of 2019)
Table 23. Global Recombinant DNA Technology by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Recombinant DNA Technology Product Solution and Service
Table 26. Date of Enter into Recombinant DNA Technology Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Recombinant DNA Technology Market Size by Type (2015-2020) (Million US$)
Table 29. Global Recombinant DNA Technology Market Size Share by Type (2015-2020)
Table 30. Global Recombinant DNA Technology Revenue Market Share by Type (2021-2026)
Table 31. Global Recombinant DNA Technology Market Size Share by Application (2015-2020)
Table 32. Global Recombinant DNA Technology Market Size by Application (2015-2020) (Million US$)
Table 33. Global Recombinant DNA Technology Market Size Share by Application (2021-2026)
Table 34. North America Key Players Recombinant DNA Technology Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Recombinant DNA Technology Market Share (2019-2020)
Table 36. North America Recombinant DNA Technology Market Size by Type (2015-2020) (Million US$)
Table 37. North America Recombinant DNA Technology Market Share by Type (2015-2020)
Table 38. North America Recombinant DNA Technology Market Size by Application (2015-2020) (Million US$)
Table 39. North America Recombinant DNA Technology Market Share by Application (2015-2020)
Table 40. Europe Key Players Recombinant DNA Technology Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Recombinant DNA Technology Market Share (2019-2020)
Table 42. Europe Recombinant DNA Technology Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Recombinant DNA Technology Market Share by Type (2015-2020)
Table 44. Europe Recombinant DNA Technology Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Recombinant DNA Technology Market Share by Application (2015-2020)
Table 46. China Key Players Recombinant DNA Technology Revenue (2019-2020) (Million US$)
Table 47. China Key Players Recombinant DNA Technology Market Share (2019-2020)
Table 48. China Recombinant DNA Technology Market Size by Type (2015-2020) (Million US$)
Table 49. China Recombinant DNA Technology Market Share by Type (2015-2020)
Table 50. China Recombinant DNA Technology Market Size by Application (2015-2020) (Million US$)
Table 51. China Recombinant DNA Technology Market Share by Application (2015-2020)
Table 52. Japan Key Players Recombinant DNA Technology Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Recombinant DNA Technology Market Share (2019-2020)
Table 54. Japan Recombinant DNA Technology Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Recombinant DNA Technology Market Share by Type (2015-2020)
Table 56. Japan Recombinant DNA Technology Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Recombinant DNA Technology Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Recombinant DNA Technology Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Recombinant DNA Technology Market Share (2019-2020)
Table 60. Southeast Asia Recombinant DNA Technology Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Recombinant DNA Technology Market Share by Type (2015-2020)
Table 62. Southeast Asia Recombinant DNA Technology Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Recombinant DNA Technology Market Share by Application (2015-2020)
Table 64. India Key Players Recombinant DNA Technology Revenue (2019-2020) (Million US$)
Table 65. India Key Players Recombinant DNA Technology Market Share (2019-2020)
Table 66. India Recombinant DNA Technology Market Size by Type (2015-2020) (Million US$)
Table 67. India Recombinant DNA Technology Market Share by Type (2015-2020)
Table 68. India Recombinant DNA Technology Market Size by Application (2015-2020) (Million US$)
Table 69. India Recombinant DNA Technology Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Recombinant DNA Technology Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Recombinant DNA Technology Market Share (2019-2020)
Table 72. Central & South America Recombinant DNA Technology Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Recombinant DNA Technology Market Share by Type (2015-2020)
Table 74. Central & South America Recombinant DNA Technology Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Recombinant DNA Technology Market Share by Application (2015-2020)
Table 76. Monsanto Company Company Details
Table 77. Monsanto Company Business Overview
Table 78. Monsanto Company Product
Table 79. Monsanto Company Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 80. Monsanto Company Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Product
Table 84. Roche Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 85. Roche Recent Development
Table 86. Biogen Company Details
Table 87. Biogen Business Overview
Table 88. Biogen Product
Table 89. Biogen Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 90. Biogen Recent Development
Table 91. Amgen Company Details
Table 92. Amgen Business Overview
Table 93. Amgen Product
Table 94. Amgen Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 95. Amgen Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Product
Table 99. Novartis Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 100. Novartis Recent Development
Table 101. Eli Lilly and Company Company Details
Table 102. Eli Lilly and Company Business Overview
Table 103. Eli Lilly and Company Product
Table 104. Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 105. Eli Lilly and Company Recent Development
Table 106. GenScript Company Details
Table 107. GenScript Business Overview
Table 108. GenScript Product
Table 109. GenScript Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 110. GenScript Recent Development
Table 111. Pfizer Inc. Business Overview
Table 112. Pfizer Inc. Product
Table 113. Pfizer Inc. Company Details
Table 114. Pfizer Inc. Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 115. Pfizer Inc. Recent Development
Table 116. Novo Nordisk Company Details
Table 117. Novo Nordisk Business Overview
Table 118. Novo Nordisk Product
Table 119. Novo Nordisk Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 120. Novo Nordisk Recent Development
Table 121. Sanofi Company Details
Table 122. Sanofi Business Overview
Table 123. Sanofi Product
Table 124. Sanofi Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 125. Sanofi Recent Development
Table 126. Merck KGaA Company Details
Table 127. Merck KGaA Business Overview
Table 128. Merck KGaA Product
Table 129. Merck KGaA Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 130. Merck KGaA Recent Development
Table 131. Profacgen Company Details
Table 132. Profacgen Business Overview
Table 133. Profacgen Product
Table 134. Profacgen Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 135. Profacgen Recent Development
Table 136. Biocon Company Details
Table 137. Biocon Business Overview
Table 138. Biocon Product
Table 139. Biocon Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 140. Biocon Recent Development
Table 141. GlaxoSmithKline Company Details
Table 142. GlaxoSmithKline Business Overview
Table 143. GlaxoSmithKline Product
Table 144. GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 145. GlaxoSmithKline Recent Development
Table 146. Cibus Company Details
Table 147. Cibus Business Overview
Table 148. Cibus Product
Table 149. Cibus Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 150. Cibus Recent Development
Table 151. Horizon Discovery Group Company Details
Table 152. Horizon Discovery Group Business Overview
Table 153. Horizon Discovery Group Product
Table 154. Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 155. Horizon Discovery Group Recent Development
Table 156. New England Biolabs Company Details
Table 157. New England Biolabs Business Overview
Table 158. New England Biolabs Product
Table 159. New England Biolabs Revenue in Recombinant DNA Technology Business (2015-2020) (Million US$)
Table 160. New England Biolabs Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant DNA Technology Market Share by Type: 2020 VS 2026
Figure 2. Therapeutic Agent Features
Figure 3. Vaccine Features
Figure 4. Biotech Crops Features
Figure 5. Specialty Chemicals Features
Figure 6. Global Recombinant DNA Technology Market Share by Application: 2020 VS 2026
Figure 7. Biotechnology and Pharmaceutical Companies Case Studies
Figure 8. Academic & Government Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Recombinant DNA Technology Report Years Considered
Figure 11. Global Recombinant DNA Technology Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Recombinant DNA Technology Market Share by Regions: 2020 VS 2026
Figure 13. Global Recombinant DNA Technology Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Recombinant DNA Technology Market Share by Players in 2019
Figure 16. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA Technology as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Recombinant DNA Technology Revenue in 2019
Figure 18. North America Recombinant DNA Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Recombinant DNA Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Recombinant DNA Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Recombinant DNA Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Recombinant DNA Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Recombinant DNA Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Recombinant DNA Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

---